▶️ Neurological symptoms of hypophosphatasia: unifyrare.com/en/closing-t... Programme initiated and funded by Alexion, AstraZeneca Rare Disease. Brought to you by COR2ED Medical Affairs. Intended for healthcare professionals only. M/GL/Med HPP/0101 | Dec 2025

We're proud to share that more than 50k HCPs now follow us online!🎉 >25k YouTube subscribers >25k social media followers Follow us for engaging #medicaleducation developed by renowned medical experts & endorsed by Medical Societies & Patient Advocacy Groups www.youtube.com/@cor2edthehe... #MedSky

ESMO 2025: Gastric and gastroesophageal cancer insights for clinical practice On-demand video and slides from an Experts Knowledge Share event ▶️ cor2ed.com/gi-connect/p... Supported by an Independent Educational Grant from Amgen #MedEd #MedicalEducation

#Hypophosphatasia across 3 generations – can you help make their dream a reality? ▶️ unifyrare.com/en/closing-t... Programme initiated and funded by Alexion, AstraZeneca Rare Disease. Brought to you by COR2ED Medical Affairs. Intended for healthcare professionals only. M/GL/Med HPP/0099 | Dec 2025

Closing the Gap in HPP Care 2025 webapp.spotme.com/login/alexio... 📅 2 & 4 December | Live sessions Initiated and funded by Alexion, AstraZeneca Rare Disease and brought to you in collaboration with COR2ED Medical Affairs. Intended for healthcare professionals only. M/GL/Med HPP/0096 | Nov 2025

Today is #WorldHPPDay #Hypophosphatasia (HPP) is a #RareDisease that can impact working, connecting, and living independently In the video (GL/UNB-H/0096), Suzanne & Amy share their HPP stories 📺 This material has been initiated and funded by Alexion Pharmaceuticals. 10/2025 GL/UNB-H/0095

Rethinking HPP (hypophosphatasia) ➡️ HPP is an inherited disorder that can impact a patient’s ability to work, connect, and live independently Watch the video (GL/UNB-H/0087) for key facts 📺 This material has been initiated and funded by Alexion Pharmaceuticals. 10/2025 GL/UNB-H/0091 #RareDiseases

Colleagues at #ESMO25 , Join our Collaborators at COR2ED and Dr. Lizzy Smyth straight from Berlin 👉 cor2ed.com/esmo-2025/up... Dr Smyth will review key studies including MATTERHORN, LEAP-014, and SKYSCRAPER-07 — and discuss whether these results could change clinical practice.

Colleagues at #ESMO25 Dr Herbert Loong shares his perspectives on the latest data on oncogene-addicted non-small cell lung cancer (NSCLC) presented at ESMO 2025. Go to the COR2ED website to watch his video update and download the accompanying slides cor2ed.com/esmo-2025/on...

Prof. Viktor Grünwald shares his renal cell carcinoma highlights from ESMO 2025 as he reviews the latest data from the LenCabo, KEYMAKER-U03 and CLEAR studies. He also discusses staging of disease with the radiolabelled peptide ([68Ga]Ga-DPI-4452). cor2ed.com/esmo-2025/re...

Dear Colleagues, Our Collaborators at COR2ED Invite you to watch Highlights from #ESMO25 WATCH HERE 👉 cor2ed.com/esmo-2025/br... Straight from Berlin, Experts share their views on new data on #BreastCancer & #GynOnc NOW ON DEMAND

Exploring the role of targeted radiopharmaceutical treatment in NETs Experts discuss PRRT and emerging strategies in neuroendocrine tumours 📹 Watch the video Supported by an Independent Educational Grant from ITM #MedEd #MedSky

How can new clinical trials in radioligand therapy impact clinical practice in #NET treatment strategies? Find out in this new #MedEd video from medical experts cor2ed.com/net-connect/... Supported by an Independent Educational Grant from ITM @nanets.bsky.social #MedSky #medicaleducation 📷

📢 New #dermatology micro learning! Improving acne vulgaris with multimodal treatment strategies >> cor2ed.com/dermatology-... 📺 4-min video, downloadable flashcard & slides, and accredited assessment Supported by an Independent Educational Grant from Glenmark Pharmaceuticals #MedSky

ADC breast cancer trials to look out for in 2025 ⬇️ #MedSky #MedEd

🔎 Expert insights on recent #BreastCancer data Dr Paolo Tarantino discusses data from SERENA-6, ASCENT-04/KEYNOTE-D19 & DESTINY-Breast09 studies presented at #ASCO25 Watch his video & see more ASCO updates ▶️ cor2ed.com/n-connect/pr... Supported by COR2ED #MedEd #MedSky @ptarantinomd.bsky.social

🚨 Best practices in managing early relapsed/refractory multiple myeloma 3-part video series with expert insights & downloadable slide sets ⬇️ cor2ed.com/lymphoma-mye... Supported by an Independent Educational Grant from Menarini Stemline Oncology #MedSky #MedEd #RRMM

➡️Tx strategies for pts w/ advanced #HCC who are ineligible for #immunotherapy or with progression on #IO 👉 cor2ed.com/hcc-connect/... Endorsed by @digestivecancerseu.bsky.social @bluefaeryliver.bsky.social @aasldnews.bsky.social @europeliver.bsky.social Supported by an IME Grant from Bayer #meded

Congratulations to the newly elected ESMO Directors & Nomination Committee members! A special mention to: 👏 GI CONNECT's Dr @lizzysmyth.bsky.social 👏 PRECISION ONCOLOGY CONNECT's Prof. Ulrik Lassen 👏 Prof. Rachel Riechelmann, who has collaborated with NET CONNECT #MedicalEducation #ESMO #MedSky

📹 Watch the video > cor2ed.com/n-connect/pr... Video: The evolution of our understanding that led us to rethink #hypophosphatasia (HPP) 💡 w/ Dr Chad Deal Programme initiated & funded by Alexion Pharmaceuticals. Intended for healthcare professionals only. GL/UNB-H/0074 #MedEd #MedSky #EULAR2025

📣Update from #ASCO25 Expert insights on the latest data: cor2ed.com/n-connect/pr... #NSCLC #ProstateCancer #GICancer #BreastCancer #OvarianCancer #CervicalCancer NSCLC update supported by an Independent Educational Grant from Bayer.Other updates supported by COR2ED #MedEd @lizzysmyth.bsky.social

📹 Watch the video: cor2ed.com/n-connect/pr... Video: Recognising #hypophosphatasia (HPP)🔍 - Key manifestations - Common misdiagnoses w/ Dr Chad Deal Programme initiated & funded by Alexion Pharmaceuticals. Intended for healthcare professionals only. GL/UNB-H/0074 #MedEd #EULAR2025

📣Highlights from #ESMO Breast Cancer 2025 Satellite Symposium Experts discuss treatment strategies/sequencing after ET+CDK4/6i for ER+/HER2- metastatic #breastcancer cor2ed.com/n-connect/pr... This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only

Chemotherapy strategies in mPDAC ➡️How to choose & optimise the different chemotherapeutic options at 1st & 2nd line w/ Profs. Efrat Dotan & Shubham Pant 📹 Watch the video/listen on Spotify/Apple cor2ed.com/gi-connect/p... Supported by an Independent Educational Grant from Ipsen USA #MedEd

New 2-part animated video series! 🎬 Ep.1 ➡️ 1st line chemotherapy options, key trial data & considering targeted therapy Ep.2 ➡️ 2nd line chemotherapy options & how earlier treatments impact sequencing cor2ed.com/gi-connect/p... Supported by an Independent Educational Grant from Ipsen USA #MedEd

🎙️#MedEd podcast 'The #HER2 diagnostic and treatment landscape in #NSCLC' > Ep. 2: Navigating common treatment scenarios in HER2-mutant NSCLC ➡️w/ @oncbrothers.bsky.social Watch the video/listen on Spotify/Apple: cor2ed.com/lung-connect... Supported by an Independent Educational Grant from Bayer

📢 New #lungcancer podcast! 'The #HER2 diagnostic and treatment landscape in #NSCLC' >> Episode 1: Identifying HER2-directed NSCLC w/@oncbrothers.bsky.social Watch the video/listen on Spotify/Apple👇 cor2ed.com/lung-connect... Supported by an Independent Educational Grant from Bayer #MedEd

What do oncology nurses in the USA think about the ways their roles are changing? GI NURSES CONNECT set out to answer this question in a recent survey 📊 The findings were published in the journal 'Healthcare' Find out more: cor2ed.com/gi-nurses-co... Supported by an IME grant from Bayer #MedEd

HCC micro learning 🎓 The expanding role of immunotherapy in HCC > Combining locoregional & systemic treatments in intermediate HCC Video, slides, flashcard + accredited assessment 👉 cor2ed.com/hcc-connect/... AstraZeneca has provided a sponsorship grant towards this independent programme #MedEd

TROPION-Breast01 final OS results did not reach statistical significance; however, subsequent ADC Tx may have influenced survival outcomes Update on the latest data from #ESMO Virtual Plenary 2025👇 cor2ed.com/breast-cance... Supported by an Independent Educational Grant from AstraZeneca #MedEd

📢 Key insights from the Phase 3 LEAP-012 study ➡️Lenvatinib + pembrolizumab + TACE versus double placebo + TACE for patients with intermediate #HCC w/Prof. @arndtvogel.bsky.social cor2ed.com/hcc-connect/... This Independent programme has been sponsored by Eisai Europe Limited ("Eisai") #MedEd

➡️ #Breastcancer highlights from the 13th #APBCS Satellite Symposium w/ Profs. Dawood, McArthur, Cortés & Penault-Llorca Watch the video update👉 cor2ed.com/n-connect/pr... This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only #MedEd #Oncology

📣New video podcast! ➡️ Exploring the latest insights in #moleculartesting & targeted therapy for HR+/HER2- metastatic breast cancer w/ Dr Callahan & Dr Salgado Listen on Spotify/Apple : cor2ed.com/precision-on... Supported by an Independent Educational Grant from Thermo Fisher Scientific #MedEd

ER+/HER2- early #breastcancer: Current & future Tx strategies 📺 Profs. Gnant & Curigliano share an update from #SGBCC2025 See more + get the slides 👉 cor2ed.com/n-connect/pr... This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only #MedEd

New #MedEd video podcast from #OBGYN experts ‘Molecular classification and treatment decisions in advanced or recurrent #endometrialcancer’ Watch/listen 👉 cor2ed.com/obstetrics-g... This independent programme has been sponsored by Eisai Europe Limited ("Eisai"). #MedEd #Oncology